Body site-dependent variations of microbiota in pancreatic cancer pathophysiology.

Lack of specific symptoms and reliable biomarkers, along with aggressive nature and resistance to therapies makes pancreatic cancer (PC) one of the leading causes of death from cancer worldwide. The search for new diagnostic, prognostic, predictive, and therapeutic tools that could improve clinical...

Descripción completa

Detalles Bibliográficos
Publicado en:Critical Reviews in Clinical Laboratory Sciences Vol. 56; no. 4; pp. 260 - 274
Autores principales: Panebianco, Concetta, Pazienza, Valerio
Formato: pictorial review Journal Article
Publicado: Taylor & Francis Ltd Jun2019
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=137143963&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 137143963
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10408363
        1AV
      jtl: Critical Reviews in Clinical Laboratory Sciences
      issn: 10408363
      maglogo: Y
    pubinfo:
      dt: Jun2019
      vid: 56
      iid: 4
      pid: 377
      pub: Taylor & Francis Ltd
      place: Philadelphia, Pennsylvania
    artinfo:
      ui:
        137143963
        137143963
        137143963
        10.1080/10408363.2019.1615407
        137143963
      ppf: 260
      ppct: 14
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: P
      tig:
        atl: Body site-dependent variations of microbiota in pancreatic cancer pathophysiology.
      aug:
        au:
          Panebianco, Concetta
          Pazienza, Valerio
        affil: Division of Gastroenterology, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
      sug:
        subj:
          Pancreatic Neoplasms Physiopathology
          Microbiota Physiology
          Biological Markers
          Homeostasis
          Helicobacter Pylori
          Pancreatic Neoplasms Prognosis
      ab: Lack of specific symptoms and reliable biomarkers, along with aggressive nature and resistance to therapies makes pancreatic cancer (PC) one of the leading causes of death from cancer worldwide. The search for new diagnostic, prognostic, predictive, and therapeutic tools that could improve clinical outcomes of patients has led, in recent years, to the investigation of potential roles for the microbiota in the pathogenesis of this disease. The human microbiota encompasses trillions of microorganisms residing within several body tissues and organs, where they provide beneficial functions for host homeostasis and health. Derangements of the microbial ecology in different anatomic districts have been described in PC, as in many other diseases, both in patients and in animal models. In detail, infection from the gastric pathogen Helicobacter pylori and changes in composition and diversity of oral, intestinal, and pancreatic microbiota have been found to associate with PC. Future research should assess how to potentially exploit such differences in microbiota composition as diagnostic, prognostic, or predictive biomarkers, and as targets for therapeutic interventions, in the hope of improving the dismal prognosis of this insidious cancer.
      pubtype: Academic Journal
      doctype:
        pictorial
        review
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N